What does BIOCIDAL ALTERNATIVE SOLUTIONS do?

BIOCIDAL ALTERNATIVE SOLUTIONS is a research organisation in Engis. Public Limited, started on 13 July 2016, 1 establishment.

What is the address of BIOCIDAL ALTERNATIVE SOLUTIONS?

The registered office of BIOCIDAL ALTERNATIVE SOLUTIONS is located at Rue des Tuiliers 4, 4480 Engis.

Is BIOCIDAL ALTERNATIVE SOLUTIONS still active?

Yes. According to the CBE (30 October 2026) BIOCIDAL ALTERNATIVE SOLUTIONS is active, legal situation “Normale toestand”, started on 13 July 2016.

Is BIOCIDAL ALTERNATIVE SOLUTIONS registered on Peppol?

Yes, BIOCIDAL ALTERNATIVE SOLUTIONS is registered on the Peppol network with ID 0208:0658960293.

What is the enterprise number of BIOCIDAL ALTERNATIVE SOLUTIONS?

The enterprise number of BIOCIDAL ALTERNATIVE SOLUTIONS is BE0658960293.

When was BIOCIDAL ALTERNATIVE SOLUTIONS founded?

BIOCIDAL ALTERNATIVE SOLUTIONS was founded on 13 July 2016.

Who are the directors of BIOCIDAL ALTERNATIVE SOLUTIONS?

According to the 2025 annual accounts, the directors of BIOCIDAL ALTERNATIVE SOLUTIONS are: Philippe SAMAIN, Estelle SOMMACAL, Thomas DETRY, Morgan HANS.

Is BIOCIDAL ALTERNATIVE SOLUTIONS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 July 2016; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did BIOCIDAL ALTERNATIVE SOLUTIONS make in 2025?

BIOCIDAL ALTERNATIVE SOLUTIONS posted a profit after taxes of € 88,050 in financial year 2025.

What is the revenue of BIOCIDAL ALTERNATIVE SOLUTIONS?

As a small company, BIOCIDAL ALTERNATIVE SOLUTIONS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 416,010.

How much does an employee at BIOCIDAL ALTERNATIVE SOLUTIONS earn?

The average wage cost per full-time employee at BIOCIDAL ALTERNATIVE SOLUTIONS was € 74,100 in 2024: staff costs of € 222,259 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

BIOCIDAL ALTERNATIVE SOLUTIONS (Public Limited) - Engis

Dossier BIOCIDAL ALTERNATIVE SOLUTIONS, printed on 30 October 2026 from databakkes.be/en/0658960293/biocidal-alternative-solutions. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BIOCIDAL ALTERNATIVE SOLUTIONS from Engis, company number BE0658960293, closed financial year 2025 with a result of € 88,050 after tax. For that financial year BIOCIDAL ALTERNATIVE SOLUTIONS recorded a gross margin of € 416,010 and equity of € 785,112. Compared with financial year 2024, the result moved from € 54,066 to € 88,050. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.

What it is worth Growing

€ 785,112

▲ 32% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 88,050

▲ 63% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 353,619

▲ € 345,278 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 20,000 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Wage cost

€ 234,298

▲ 5% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 17,643

▼ 39% vs 2024

€ 11,700 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 172,339

▲ 113% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,672

▲ 1% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 469,143 Gross margin 2022: € 469,143 First fiscal year in the series	€ 450,159 Gross margin 2023: € 450,159 ▼ 4% vs 2022 (€ 469,143) Unfavourable step	€ 365,548 Gross margin 2024: € 365,548 ▼ 19% vs 2023 (€ 450,159) Unfavourable step	€ 416,010 Gross margin 2025: € 416,010 ▲ 14% vs 2024 (€ 365,548) Favourable step	▲ 14%
Profit after taxes	€ 68,972 Profit after taxes 2022: € 68,972 First fiscal year in the series	€ 93,446 Profit after taxes 2023: € 93,446 ▲ 35% vs 2022 (€ 68,972) Favourable step	€ 54,066 Profit after taxes 2024: € 54,066 ▼ 42% vs 2023 (€ 93,446) Unfavourable step	€ 88,050 Profit after taxes 2025: € 88,050 ▲ 63% vs 2024 (€ 54,066) Favourable step	▲ 63%
Equity	€ 490,040 Equity 2022: € 490,040 First fiscal year in the series	€ 560,882 Equity 2023: € 560,882 ▲ 14% vs 2022 (€ 490,040) Favourable step	€ 593,055 Equity 2024: € 593,055 ▲ 6% vs 2023 (€ 560,882) Favourable step	€ 785,112 Equity 2025: € 785,112 ▲ 32% vs 2024 (€ 593,055) Favourable step	▲ 32%
Total debts	€ 280,931 Total debts 2022: € 280,931 First fiscal year in the series	€ 411,682 Total debts 2023: € 411,682 ▲ 47% vs 2022 (€ 280,931) Unfavourable step	€ 421,024 Total debts 2024: € 421,024 ▲ 2% vs 2023 (€ 411,682) Unfavourable step	€ 428,228 Total debts 2025: € 428,228 ▲ 2% vs 2024 (€ 421,024) Unfavourable step	▲ 2%
Cash	€ 171,363 Cash 2022: € 171,363 First fiscal year in the series	€ 9,641 Cash 2023: € 9,641 ▼ 94% vs 2022 (€ 171,363) Unfavourable step	€ 8,341 Cash 2024: € 8,341 ▼ 13% vs 2023 (€ 9,641) Unfavourable step	€ 353,619 Cash 2025: € 353,619 ▲ € 345,278 vs 2024 (€ 8,341) Favourable step	▲ € 345,278
Retained profit	€ 252,642 Retained profit 2022: € 252,642 First fiscal year in the series	€ 326,088 Retained profit 2023: € 326,088 ▲ 29% vs 2022 (€ 252,642) Favourable step	€ 360,154 Retained profit 2024: € 360,154 ▲ 10% vs 2023 (€ 326,088) Favourable step	€ 428,204 Retained profit 2025: € 428,204 ▲ 19% vs 2024 (€ 360,154) Favourable step	▲ 19%
Dividend	€ 20,000 Dividend 2022: € 20,000 First fiscal year in the series	€ 20,000 Dividend 2023: € 20,000 Unchanged (€ 20,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 Unchanged (€ 20,000) Unchanged	€ 20,000 Dividend 2025: € 20,000 Unchanged (€ 20,000) Unchanged
Bank debt	€ 81,068 Bank debt 2022: € 81,068 First fiscal year in the series	€ 47,502 Bank debt 2023: € 47,502 ▼ 41% vs 2022 (€ 81,068) Favourable step	€ 29,097 Bank debt 2024: € 29,097 ▼ 39% vs 2023 (€ 47,502) Favourable step	€ 17,643 Bank debt 2025: € 17,643 ▼ 39% vs 2024 (€ 29,097) Favourable step	▼ 39%
Balance sheet total	€ 770,972 Balance sheet total 2022: € 770,972 First fiscal year in the series	€ 972,564 Balance sheet total 2023: € 972,564 ▲ 26% vs 2022 (€ 770,972) Unchanged	€ 1,014,080 Balance sheet total 2024: € 1,014,080 ▲ 4% vs 2023 (€ 972,564) Unchanged	€ 1,213,340 Balance sheet total 2025: € 1,213,340 ▲ 20% vs 2024 (€ 1,014,080) Unchanged	▲ 20%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	3.2 Employees (FTE) 2023: 3.2 ▼ 0.3 vs 2022 (3.5) Unchanged	3 Employees (FTE) 2024: 3 ▼ 0.2 vs 2023 (3.2) Unchanged	-

Key figures of BIOCIDAL ALTERNATIVE SOLUTIONS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOCIDAL ALTERNATIVE SOLUTIONS?

What happened at BIOCIDAL ALTERNATIVE SOLUTIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2028 Estelle SOMMACAL stepped down as director. NBB
2028 Thomas DETRY stepped down as director. NBB
2028 Morgan HANS stepped down as director. NBB
Jun 9, 2026 New annual accounts for financial year 2025: profit of € 88,050 (▲ 63% vs 2024). Source: NBB ↗
2025 Philippe SAMAIN stepped down as director. NBB
2025 Morgan HANS became a director. NBB
2022 Philippe SAMAIN became a director. NBB
2022 Estelle SOMMACAL became a director. NBB

In short

From € 68,972 profit in 2022 to € 88,050 profit in 2025.

Paid € 3,062 in corporate taxes since 2022.

Best year ever: 2023, with € 93,446 profit.

On average € 121,800 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Philippe SAMAIN

Managing director

Also active at: PHYSAM

since 2022 · until 2025

Estelle SOMMACAL

Director

since 2022 · until 2028

Thomas DETRY

Director

since 2022 · until 2028

Morgan HANS

Managing director

since 2025 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Tuiliers 4

4480 Engis

2.255.217.039

Rue de la Charmille 16

4577 Modave

Active since 13 July 2016

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0658.960.293

VAT number

BE 0658.960.293

Registered office

Rue des Tuiliers 4, 4480 Engis

Names & denominations

BIOCIDAL ALTERNATIVE SOLUTIONS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

13 July 2016

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Groothandel in chemische producten voor industrieel gebruik

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige technische testen en toetsen

Overige gespecialiseerde wetenschappelijke en technische activiteiten